Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Denver, Colorado

Phase 1 cancer trials in Denver, CO

64 Phase 1 cancer studies are recruiting participants at sites in Denver as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Denver at a glance

Breast cancer studies recruiting in Denver

Basic details from each study's public record (the 30 most recently updated of 64). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07503808 · updated
  2. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 19 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    SCRI at HealthOne
    Registry record
    NCT06586957 · updated
  3. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07029399 · updated
  4. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Sarah Cannon Research Institute at HealthOne
    Registry record
    NCT06465069 · updated
  5. A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cogent Biosciences, Inc.
    Study site
    Sarah Cannon Research Institute (SCRI) at HealthONE-Denver
    Registry record
    NCT07383506 · updated
  6. Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Nammi Therapeutics Inc
    Study site
    Sarah Cannon Research Institute - Denver DDU
    Registry record
    NCT06582017 · updated
  7. BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    BeOne Medicines
    Study site
    Sarah Cannon Research Institute (Scri) At Health One
    Registry record
    NCT06120283 · updated
  8. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    ModeX Therapeutics, An OPKO Health Company
    Study site
    Sarah Cannon Research Institute
    Registry record
    NCT06239194 · updated
  9. SMP-3124LP in Adults With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Sumitomo Pharma America, Inc.
    Study site
    Sarah Cannon Research Institute at HealthOne
    Registry record
    NCT06526819 · updated
  10. Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926
    Registry record
    NCT06084481 · updated
  11. A Study of PHST001 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pheast Therapeutics
    Study site
    Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One
    Registry record
    NCT06840886 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Lung cancer studies recruiting in Denver

  1. A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bayer
    Study site
    Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's
    Registry record
    NCT06914128 · updated
  2. Phase 1 Study of PF-08046033 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Presbyterian/St Lukes Medical Center · Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT07519655 · updated
  3. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Sarah Cannon Cancer Institute at HealthONE
    Registry record
    NCT06720987 · updated
  4. DBC-664 in Adult Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Duboce Biopharmaceuticals, Inc.
    Study site
    Sarah Cannon Research Institute - Denver HealthONE
    Registry record
    NCT07705035 · updated
  5. Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tango Therapeutics, Inc.
    Study site
    Sarah Cannon Research Institute Denver
    Registry record
    NCT06922591 · updated
  6. AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Avenzo Therapeutics, Inc.
    Study site
    Avenzo Therapeutics Recruiting Site
    Registry record
    NCT07038343 · updated
  7. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT06026410 · updated
  8. Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    Rocky Mountain Cancer Centers,LLP
    Registry record
    NCT07227298 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Prostate cancer studies recruiting in Denver

  1. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Study site
    Rocky Mountain Cancer Centers
    Registry record
    NCT04221542 · updated
  2. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Regeneron Pharmaceuticals
    Study site
    Sarah Cannon Research Institute (SCRI)
    Registry record
    NCT03972657 · updated
  3. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Sarah Cannon Research Institute 1
    Registry record
    NCT06800313 · updated
  4. An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Novartis Pharmaceuticals
    Study site
    Sarah Cannon Research Institute
    Registry record
    NCT07206056 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Lymphoma studies recruiting in Denver

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    Registry record
    NCT04726241 · updated
  2. A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Colorado Blood Cancer Institute ( Site 7000)
    Registry record
    NCT07519772 · updated
  3. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Colorado Blood Cancer Institute
    Registry record
    NCT07101328 · updated
  4. A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Colorado Blood Cancer Institute
    Registry record
    NCT07226843 · updated
  5. Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

    • Phase 1/2
    • Ages 13 to 90
    • All sexes
    Sponsor
    Vironexis Biotherapeutics Inc.
    Study site
    Colorado Blood Cancer Institute
    Registry record
    NCT06533579 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Denver, CO on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Denver

  1. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Sarah Cannon Research Institute at HealthONE
    Registry record
    NCT04657068 · updated
  2. A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    SCRI at HCA Health One
    Registry record
    NCT07186842 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Denver, CO on ClinicalTrials.gov.

Ask about studies near Denver

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Colorado

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call